• Systems
  • Applications
  • Support
  • News & Events
    • News
    • Events
  • About Us
    • Who Is Celsee
    • Our Team
    • Our Board
    • Careers
  • Contact Us
    • Distributors
Celsee
  • Systems
  • Applications
  • Support
  • News & Events
    • News
    • Events
  • About Us
    • Who Is Celsee
    • Our Team
    • Our Board
    • Careers
  • Contact Us
    • Distributors

News

Celsee Launches Genesis System to Overcome Prior Limits of Single-cell Analysis

Ann Arbor, Mich. – October 25, 2018 – Celsee, Inc., today launched its first product, the Genesis system, designed to overcome the limitations of other tools for single-cell analysis. The Genesis system provides a robust, scalable, and flexible way for scientists to analyze and interpret cellular behavior and collect critical cell-based information that was previously undetectable. Initial applications include proteogenomics; immune monitoring as an alternative to flow cytometry; and expansion and scale of next-generation sequencing library preparation.

The importance of analyzing individual cells, rather than relying on bulk populations or tissue-based assessment, is now well understood in fields such as oncology, stem cell research, and immunology. For many medical conditions, the cell is the fundamental unit from which to determine disease onset, progression, and potential treatment matches. Access to the genomic or proteomic content in a cell, as well as to cell cycle or state, can provide critical information that can drive a more complete understanding of disease progression and potential response to treatment. In order to obtain the most meaningful information, scientists need intact and viable cells that have not been damaged by harsh cellular analysis and manipulation processes.

“Commonly used single-cell analysis technologies lack the capture efficiency, cell viability, and reproducibility needed to achieve the scalability required for widespread use in research and clinical settings,” said John Stark, Chief Executive Officer of Celsee. “The Celsee Genesis system overcomes these deficiencies and provides clinical-grade, single-cell analysis at scale. We are excited about the opportunities to improve the experimental process in emerging fields such as proteogenomics and understanding response to immunotherapies.”

The company’s patented technology uses a gentle, gravity-based method to capture and isolate individual cells while maintaining viability and structural integrity. The Celsee Genesis workflow achieves capture efficiencies of >70% and improved sensitivity versus other commonly used techniques for single-cell analysis. The open and flexible platform can be used directly with blood and tissue samples, offering a practical solution for understanding and monitoring cell-based diseases whether users are interested in studying an individual cell or millions from a single sample.

About Celsee
Celsee, Inc., a privately held company in the Ann Arbor, Michigan area, is breaking through the traditional barriers of single-cell analysis and delivering clinical-grade technology designed to support the life sciences revolution and precision medicine. Based on a gentle, gravity-induced, micro-well isolation technique, the patented technology forms the foundation for an elegant, scalable, and flexible single-cell analysis platform that makes more experiments feasible. Celsee’s first product, the Genesis system, enables scientists to analyze and interpret cellular behavior and collect previously inaccessible information for improved results in applications such as proteogenomics, next-generation sequencing, immune monitoring, and cell therapy. For more information, visit www.celsee.com.

Media Contact:

Nicole Litchfield
Bioscribe, Inc.
415-793-6468
Nicole@bioscribe.com

 

Share
Tweet
Share

CONTACT US ABOUT THE GENESIS SYSTEM

  • Systems
  • Applications
  • Support
  • News & Events
  • About Us
  • Contact Us
  • Newsletter Sign-up

© 2019 Celsee Inc., All Rights Reserved
Privacy Policy – Terms of Use
100 Phoenix Drive – Suite 321
Ann Arbor, MI 48108

Contact us today
866.748.1448
248.319.6919


LinkedInTwitterInstagram

Contact Us


To contact us regarding general inquiries, including questions, comments, and feedback, please fill out the form below:

Terms of Use | Privacy Policy | Email Preferences Center

Contact Tech Support


Celsee is committed to your success! Our technical support team strives to provide excellent customer support and to answer any of your questions. Complete the form below and we’ll reply in a timely manner.

Contact Sales


If you would like to have a Celsee representative contact you about pricing, products, or other information, please fill out the form below:

Terms of Use | Privacy Policy

The Latest Updates on Life Sciences Technology Delivered To Your Inbox

Terms of Use | Privacy Policy

Contact Us About the Genesis System
Submit an Application

For consideration, please fill the form out below. No phone calls, please. Only qualified candidates will be contacted.

First Name*

Last Name*

Email Address*

Phone Number*

Address Line 1*

Address Line 2

City*

State/Province/Territory*

Country*

Postal Code*

Are you authorized to work in the United States?*

Will you now or in the future require sponsorship for employment visa status?*

Were you referred by an existing employee?*

If yes, who referred you?

The position you're applying for: (prefilled)

Salary Requirements:*

Upload your resume: (.pdf and .doc file only) (recommended)

Upload your coverletter: (.pdf and .doc file only) (optional)

Would you like to include additional information about yourself? (optional)

*Celsee, Inc. is an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status or any other characteristic protected by law.

We use cookies in order to improve and customize your browsing experience. By continuing, you are consenting to our privacy policy. Accept Read More
Privacy Overview
Privacy Overview +

Privacy Overview